Page last updated: 2024-11-02

pantoprazole and Genetic Predisposition

pantoprazole has been researched along with Genetic Predisposition in 1 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"A 75-year-old man developed rhabdomyolysis and acute renal failure during atorvastatin therapy."7.78Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction. ( Bacic-Vrca, V; Bozina, N; Horvatic, I; Lisicic, A; Marusic, S, 2012)
"A 75-year-old man developed rhabdomyolysis and acute renal failure during atorvastatin therapy."3.78Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction. ( Bacic-Vrca, V; Bozina, N; Horvatic, I; Lisicic, A; Marusic, S, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marusic, S1
Lisicic, A1
Horvatic, I1
Bacic-Vrca, V1
Bozina, N1

Other Studies

1 other study available for pantoprazole and Genetic Predisposition

ArticleYear
Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction.
    International journal of clinical pharmacy, 2012, Volume: 34, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Kidney Injury; Aged; Aryl Hydrocarbon Hydroxylases; A

2012